Focusing on the development strategy of the company, the company insists on the combination of independent research and development and joint research and development, focusing the main direction of research and development on pure natural plant cardiovascular and cerebrovascular drugs. With its unique R&D advantages, it has formed a product and technology development model of "screening generation, demonstration generation, project generation, research generation, listing generation and reserve generation". The company is recognized as a national high-tech enterprise with its strong scientific research strength and continuous innovation ability.
The exclusive traditional Chinese medicine protection variety "Xinkeshu Tablet" developed by Wohua Medicine has scientific formula, exact and unique curative effect, no toxic and side effects and the best cost performance. It has been put into clinical practice for more than 20 years, becoming the first choice drug for patients with cardiovascular and cerebrovascular diseases, and is favored by doctors and patients. It was rated as a famous brand product of traditional Chinese medicine in China. The "Xinkeshu Dripping Pill" project under development is listed as "National 863 Key Science and Technology Project", "National Small and Medium-sized Enterprise Science and Technology Innovation Project" and "Shandong High-tech Key Project" respectively. Other series of drugs around cardiovascular and cerebrovascular pure natural plants have obtained production numbers, and some of them are under planned research and development.